Twist Bioscience Corporation (TWST) Misses Q4 EPS by 5c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.84), $0.05 worse than the analyst estimate of ($0.79). Revenue for the quarter came in at $38 million versus the consensus estimate of $37.02 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2022 revenue of $183-193 million, versus the consensus of $131.11 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Vail Resorts taps bankers for potential activist defense, Semafor reports
• SanDisk and Micron surge as Apple confirms memory price pass-through